Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer.

Criscuolo, Daniela; Avolio, Rosario; Parri, Matteo; Romano, Simona; Chiarugi, Paola; Matassa, Danilo Swann; Esposito, Franca

Criscuolo, Daniela; Avolio, Rosario; Parri, Matteo; Romano, Simona; Chiarugi, Paola; Matassa, Danilo Swann; Esposito, Franca.

Afiliación

Criscuolo D; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
Avolio R; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
Parri M; Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy.
Romano S; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
Chiarugi P; Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy.
Matassa DS; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
Esposito F; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.

Antioxidants (Basel) ; 11(8)2022 Aug 10.

Article en En | MEDLINE | ID: mdl-36009263

Palabras clave

GSH; ovarian cancer; platinum resistance; reactive oxygen species (ROS)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Antioxidants (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google